• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Braz J Microbiol . Viral isolation allows characterization of early samples of SARS-CoV-2 lineage B1.1.33 with unique mutations (S: H655Y and T63N)

tetano

Editor, Senior Moderator
Braz J Microbiol


. 2022 Jul 1.
doi: 10.1007/s42770-022-00789-z. Online ahead of print.
Viral isolation allows characterization of early samples of SARS-CoV-2 lineage B1.1.33 with unique mutations (S: H655Y and T63N) circulating in Southern Brazil in 2020


Juliana Schons Gularte[SUP] 1 [/SUP], Mariana Soares da Silva[SUP] 2 [/SUP], Micheli Filippi[SUP] 2 [/SUP], Meriane Demoliner[SUP] 2 [/SUP], Karoline Schallenberger[SUP] 2 [/SUP], Alana Witt Hansen[SUP] 2 [/SUP], Vyctoria Malayhka de Abreu Góes Pereira[SUP] 2 [/SUP], Fágner Henrique Heldt[SUP] 2 [/SUP], Viviane Girardi[SUP] 2 [/SUP], Matheus Nunes Weber[SUP] 2 [/SUP], Paula Rodrigues de Almeida[SUP] 2 [/SUP], Bruno Lopes Abbadi[SUP] 3 [/SUP], Maiele Dornelles[SUP] 3 [/SUP], Cristiano Valim Bizarro[SUP] 3 [/SUP], Pablo Machado[SUP] 3 [/SUP], Luiz Augusto Basso[SUP] 3 [/SUP], Odir Antonio Dellagostin[SUP] 4 [/SUP], Juliane Deise Fleck[SUP] 2 [/SUP], Fernando Rosado Spilki[SUP] 2 [/SUP]



Affiliations

Abstract

Different approaches are in use to improve our knowledge about the causative agent of coronavirus disease (COVID-19). Cell culture-based methods are the better way to perform viral isolation, evaluate viral infectivity, and amplify the virus. Furthermore, next-generation sequencing (NGS) have been essential to analyze a complete genome and to describe new viral species and lineages that have arisen over time. Four naso-oropharyngeal swab samples, collected from April to July of 2020, were isolated and sequenced aiming to produce viral stocks and analyze the mutational profile of the found lineage. B.1.1.33 was the lineage detected in all sequences. Although the samples belong to the same lineage, it was possible to evaluate different mutations found including some that were first described in these sequences, like the S:H655Y and T63N. The results described here can help to elicit how the pandemic started to spread and how it has been evolving in south Brazil.

Keywords: B.1.1.33; S:H655Y; S:T63N; SARS-CoV-2; Southern Brazil.
 
Back
Top Bottom